Compare VRA & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRA | STIM |
|---|---|---|
| Founded | 1982 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.4M | 140.6M |
| IPO Year | 2010 | 2018 |
| Metric | VRA | STIM |
|---|---|---|
| Price | $3.43 | $1.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 194.0K | ★ 2.2M |
| Earning Date | 06-10-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.47 | ★ 57.25 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $416,097,000.00 | $52,776,000.00 |
| Revenue This Year | N/A | $11.10 |
| Revenue Next Year | $2.50 | $11.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $0.80 |
| 52 Week High | $4.39 | $4.84 |
| Indicator | VRA | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 37.17 | 40.89 |
| Support Level | $1.95 | $1.23 |
| Resistance Level | $3.80 | $1.55 |
| Average True Range (ATR) | 0.22 | 0.22 |
| MACD | -0.12 | -0.07 |
| Stochastic Oscillator | 11.47 | 4.49 |
Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.